A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Canada: A recent study published in the Multiple Sclerosis Journal has revealed that individuals who experienced psychiatric ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

Alzheimer’s disease is relentless. It gradually affects memory, independence, and the ability to manage everyday activities.

The country music world has lost some iconic names in 2025, and sadly the list kept on growing in December. As we close out ...

These days, it’s hard to miss cannabis dispensaries. In the 40 states (plus DC) that have legalised medical marijuana, ...

Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) The CTA No ...

The CTA No Objection Letter from Health Canada allows for initiation of patient enrollment in the ALSTARS Trial at Canadian ALS centers. The ALSTARS Trial is a phase 2, placebo-controlled study that ...

I was told that 50% of people with MND die within three years; 90% within 10. There’s no cure and nothing to slow it down. In ...